-31.0%
MRNA vs DOV
+17.2%
-48.2%
-93.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | DOV | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -2.8% | +0.6% | -0.2% |
| 7D | -12.7% | -7.5% | -5.2% | -7.9% |
| 30D | -20.7% | -2.8% | -17.9% | -18.8% |
| 3M | +46.3% | -2.5% | +48.8% | +48.9% |
| 6M | +305.2% | -7.4% | +312.7% | +320.8% |
| YTD | +561.2% | +0.3% | +561.0% | +541.6% |
| 1Y | +772.1% | +10.3% | +761.8% | +687.9% |
| 3Y | +147.0% | +45.3% | +101.6% | +82.3% |
| All | -31.0% | +17.2% | -48.2% | -48.7% |
Cumulative growth
Daily Returns
Daily percentage return beside DOV.
Daily Out/Under-Performance
Portfolio return minus DOV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × DOV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded DOV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling